Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

Summary

This phase I trial is studying the side effects and best dose of decitabine in treating patients with metastatic or unresectable refractory solid tumors or lymphomas. Drugs used in chemotherapy, such as decitabine, work in different ways to stop cancer cells from dividing so they stop growing or die

Timeline

Start

2004-09

Primary completion

2008-03

Completion

—

Drugs

Indications